MRI total sagittal abdominal diameter as a predictor of metabolic syndrome compared to visceral fat at L4-L5 level

Current Medical Research and Opinion

Volumn 24, Issue 7, 2008, Pages 1853-1860

  Valsamakis, G ^a   Jones, A ^b   Chetty, R ^b   McTernan, P G ^c   Boutsiadis, A ^a   Barnett, A H ^b   Banerjee, A K ^b   Kumar, S ^c  

^a Evgenidion Hospital   (Greece)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

ATPIII criteria; Central; fat, antero posterior; Sagittal abdominal diameter; Visceral magnetic resonance imaging (MRI) metabolic syndrome

Indexed keywords

ADIPOCYTOKINE;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CAUCASIAN; CLINICAL ARTICLE; HUMAN; INTRAABDOMINAL FAT; LOGISTIC REGRESSION ANALYSIS; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL SIGNIFICANCE; WAIST CIRCUMFERENCE;

ADULT; AGED; ANTHROPOMETRY; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; HUMANS; INTRA-ABDOMINAL FAT; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROGNOSIS;

EID: 47949098806     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802185757     Document Type: Article

References (29)

1. World Health Organization. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Introduction. Sydney: World Health Organization, 2000, p. 8
2. National Audit Office. Tackling Obesity in England. London: House of Commons Stationery Office, 2001; Part 1: 7-11
3. Seidell JC, Rissanen AM. Time trends in the worldwide prevalence of obesity. In: Bray GA, Bouchard C, James WPT, eds. Textbook of Obesity. New York: Marcel Dekker; 1999. pp. 41-77
4. Chan JM, Stampfer MJ, Ribb EB, et al. Obesity, fat distribution and weight gain as risk factors for clinical diabetes in man. Diab Care 1994;17:961-69
5. Kopelman PG. Obesity as a medical problem. Nature 2000;404:635-43
6. US Department of Health and Human Services. Identify metabolic syndrome and treatment. In ATPIII Guidelines at a Glance. Washington: National Institutes of Health, 2001;Publication No. 01-3305
7. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world wide-definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-80
8. Lorenzo C, Williams K, Hunt KJ, et al. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes. Diab Care 2007;30:8-13
9. Tong PC, Kong AP, Yee So W, et al. The Usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III Definitions of the Metabolic Syndrome in predicting Coronary Heart Disease in Subjects With Type 2 Diabetes. Diab Care 2007;30:1206-11
10. McTernan PG, Fisher FM, Valsamakis G, et al. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitasone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 2003;88:6098-106
11. Yaturu S, Daberry RP, Rains J, et al. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes. Cytokine 2006;34:219-23
12. Cavusoglou E, Ruwende C, Chopra V, et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2006;27:2300-9
13. Han TS, Lean MEJ. Anthropometric indices of obesity and regional distribution of fat depots. In: Bjorntorp P, ed. International Textbook of Obesity. Chichester: John Wiley and Sons; 2001. pp. 51-65
14. Valsamakis G, Chetty R, Anwar A, et al. Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo-Asian subjects. Diabet Med 2004;21:1339-45
15. Zamboni M, Turcato E, Armellini F, et al. Sagittal abdominal diameter as a practical predictor of visceral fat. Int J Obes Relat Metab Disord. 1998;22:655-60
16. Riserus U, Arnlov J, Brismar K, et al. Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. Diab Care 2004;27:2041-6
17. Petersson H, Daryani A, Riserus U. Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle east and native Swedish women: a cross sectional study. Cardiovasc Diabetol 2007;28:6-10
18. Ross R, Leger L, Morris DV, et al. Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 1992;72:787-95
19. Han TS, Kelly IE, Walsh K, et al. Relationship between volumes and areas from single transverse scans of intra-abdominal fat measured by magnetic resonance imaging. Int J Obes Relat Metab Disord 1997;21:1161-6
20. Kullberg J, von Below C, Lonn L, et al. Practical approach for estimation of subcutaneous and visceral adipose tissue. Clin Physiol Funct Imaging 2007;27:148-53
21. World Health Organisation Expert Committee. Second Report on Diabetes Mellitus. Tech Rep Ser 646. Geneva: WHO, 1980
22. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta cell function from fasting glucose and insulin concentration in man. Diabetologia 1985;28:412-19
23. Asayama K, Dobashi K, Hayashibe H, et al. Threshold values of visceral fat measures and their anthropometric alternatives for metabolic derangement in Japanese obese boys. Int J Obes Relat Metab Disord 2002;26:208-13
24. Ohrvall M, Berglund L, Vessby B. Sagittal abdominal diameter compared with other anthropometric measurements in relation to cardiovascular risk. Int J Obes Relat Metab Disord 2000;24:497-501
25. Poulliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-8
26. Turcato E, Bosello O, Di Francesco V, et al. Waist circumference and abdominal sagittal diameter as surrogates of body fat distribution in the elderly: their relation with cardiovascular risk factors. Int J Obes Relat Metab Disord 2000;24:1005-10
27. Takami R, Takeda N, Hayashi M, et al. Body fatness and fat distribution as predictors of metabolic abnormalities and early carotid atherosclerosis. Diab Care 2001;24:1248-52
28. Smith SR, Lovejoy JC, Greenway F, et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments and visceral adipose tissue to the metabolic complications of obesity. Metabolism 2001;50:425-35
29. Bullo M, Garcia-Lorda P, Megias I, et al. Systemic inflammation, adipose tissue tumor necrosis factor and leptin expression. Obes Res 2003;11:525-31